Skip to main content

Nguyen AnhCo's Form 4 filing

Atara Biotherapeutics, Inc.ATRA · filed Nov 18, 2026

Accession no.
0000905148-26-005037
Filed
Nov 18, 2026, 5:22 PM ET
Trade date
Nov 16, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $39.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nguyen AnhCoCIK 0001977970Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 16, 2026Common StockSSaleDisposed−6,094$6.46F2−$39,368.46126,681Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

The sale price of the reporting person's shares represents the weighted average price of all shares sold by a broker on November 16, 2026, and November 17, 2026, on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)